Study Maps the Complete Genetic Blueprint for Loganin Biosynthesis

Plant-derived terpenoids play essential roles in medicine, agriculture, and human health, but their biosynthesis is often complex and tightly regulated. Loganin is a key precursor for multiple therapeutic compounds and exhibits strong anticancer activity through mechanisms such as DNA topoisomerase inhibition. Despite its importance, the complete biosynthetic pathway of loganin-particularly critical hydroxylation and methylation steps-has remained unresolved, largely due to the absence of a high-quality reference genome. In addition, natural loganin accumulation is low, constraining industrial production and drug development. Based on these challenges, there is a pressing need to systematically dissect the genomic, enzymatic, and evolutionary foundations of loganin biosynthesis.

Researchers from Beijing Forestry University, in collaboration with international partners, reported (DOI: 10.1093/hr/uhaf259) their findings in January 2026 in Horticulture Research. The team generated the first chromosome-level genome assembly of Cornus officinalis, a traditional medicinal plant widely used in Chinese medicine. Combining genome sequencing, comparative genomics, enzyme structural analysis, and metabolic engineering, the study elucidates the complete biosynthetic pathway of loganin. The work identifies key biosynthetic gene clusters and a highly efficient enzyme responsible for C-9-specific hydroxylation, providing a long-sought molecular explanation for loganin production and evolution.

The researchers assembled a 2.96-Gb genome of Cornus officinalis with nine pseudochromosomes, achieving near-reference quality and revealing an unusually high abundance of transposable elements that drove genome expansion. Comparative analyses uncovered a lineage-specific whole-genome duplication event and extensive gene family expansions linked to stress adaptation and secondary metabolism.

Crucially, the study identified discrete biosynthetic gene clusters containing multiple core enzymes required for loganin production, including loganic acid O-methyltransferase (LAMT), secologanin synthase, and cytochrome P450s. Among three candidate LAMT enzymes, CoLAMT1 exhibited exceptional catalytic efficiency and strict regioselectivity for C-9 hydroxylation. Structural modeling and molecular docking pinpointed key amino acid residues that govern substrate positioning and enzymatic specificity.

To validate function, the team reconstructed the loganin biosynthetic pathway in Nicotiana benthamiana, successfully achieving de novo synthesis of loganin derivatives. CoLAMT1 produced substantially higher yields than previously characterized homologs, confirming its central role in vivo. Together, these results connect genome evolution, gene clustering, and enzyme specialization into a unified model explaining efficient loganin biosynthesis.

"This work shows how genome evolution directly shapes the production of medicinal compounds," said the study's corresponding author. "By resolving the complete biosynthetic pathway and identifying a highly efficient, C-9-specific enzyme, we not only clarify how loganin evolved in Cornus officinalis but also provide a blueprint for improving its production. These insights bridge genomics, enzymology, and synthetic biology, demonstrating how fundamental genome architecture can translate into real-world biomedical potential."

The findings have broad implications for plant biology, biotechnology, and drug development. By linking biosynthetic gene clusters to enzyme efficiency, the study offers new strategies for engineering high-yield medicinal plants or microbial production systems. The discovery of a highly active CoLAMT enzyme provides a promising scaffold for anticancer drug screening and protein engineering. More broadly, the work highlights how chromosome-scale genomics can accelerate the discovery of valuable natural products. As demand grows for sustainable sources of plant-derived therapeutics, this genome-guided approach may transform how medicinal compounds are discovered, optimized, and produced.